The European Chemicals Agency’s (ECHA) 11th recommendation to include lead metal in the REACH Authorization List raises significant concerns within the Nuclear Medicine community.
While the intention behind such regulations is undoubtedly to enhance safety and environmental protection, it is crucial to consider the potential challenges and consequences that may arise from the implementation of this ban.